Target intelligence / Profile preview

Coagulation Factor VIII (FVIII)

Target
FVIII
Molecular classification
Coagulation protein, Glycoprotein, Cofactor
01

Overview

Coagulation factor VIII (FVIII) is an essential blood clotting protein acting as a cofactor for activated factor IX (FIXa) in the activation of factor X. Deficiency or mutations in FVIII cause hemophilia A, a bleeding disorder. FVIII circulates bound to von Willebrand factor (vWF) and is activated by thrombin. Therapeutic innovations include recombinant FVIII products, gene therapy, and bispecific antibodies.

Other names
Antihemophilic factorAHFHEMA
02

Mechanism of action

Cofactor for FIXa-mediated activation of FX in the coagulation cascade, leading to thrombin generation and fibrin clot formation

03

Biological functions

Blood coagulationHemostasisActivation of Factor X
04

Disease associations

Hemophilia Avon Willebrand disease
05

Safety considerations

Inhibitor development (antibodies against FVIII)Thrombosis risk with excessive FVIII replacementImmune reactions to FVIII products
06

Interacting drugs

Recombinant FVIII

2 more in the full profile.

07

Biomarkers

FVIII plasma levelsFVIII activity

Beyond the preview

Go deeper on Coagulation Factor VIII (FVIII).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulation Factor VIII (FVIII).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call